Esoteric Testing Market Scope And Analysis

  • Report Code : TIPHE100001382
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Esoteric Testing Market Scope and Key Players Analysis by 2030

Buy Now


Esoteric Testing Market Report Scope

Report Attribute Details
Market size in 2022 US$ 25,976.97 Million
Market Size by 2030 US$ 79,777.20 Million
Global CAGR (2022 - 2030) 15.1%
Historical Data 2020-2022
Forecast period 2022-2030
Segments Covered By Type
  • Infectious Disease Testing
  • Endocrinology Testing
  • Oncology Testing
  • Toxicology Testing
  • Immunology Testing
  • Neurology Testing
By Technology
  • Chemiluminescence Immunoassay
  • Enzyme-Linked Immunosorbent Assay
  • Mass Spectrometry
  • Real-Time PCR
  • DNA Sequencing
  • Flow Cytometry
By and End User
  • Hospitals and Laboratories
  • Independent and Reference Laboratories
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Georgia Esoteric Molecular Laboratory LLC
  • Laboratory Corp of America Holdings
  • Quest Diagnostics Inc
  • National Medical Services Inc
  • OPKO Health Inc
  • ARUP Laboratories Inc
  • bioMONTR Labs
  • Athena Esoterix LLC
  • Stanford Hospital Clinics
  • Industry Developments and Future Opportunities: 

    Various initiatives taken by key players operating in the esoteric testing market are listed below:

    1. In March 2022, Waters Corporation launched the Xevo TQ Absolute system, a compact benchtop tandem mass spectrometer. This highly sensitive, latest mass spectrometer quantifies negatively ionizing compounds with up to 15-fold greater sensitivity than its predecessor, with a 45% smaller size and up to 50% less electricity and gas consumption.
    2. In February 2021, Quest Diagnostics collaborated with Grail for its Galleri multicancer blood tests. Quest Diagnostics had plans to provide phlebotomy services using the Galleri multicancer early-detection blood tests.

    Competitive Landscape and Key Companies:

    Georgia Esoteric & Molecular Laboratory LLC, Laboratory Corp of America Holdings, Quest Diagnostics Inc., National Medical Services Inc., OPKO Health Inc., ARUP Laboratories Inc., bioMONTR Labs, Athena Esoterix LLC, Stanford Hospital & Clinics, and Foundation Medicine Inc. are among the prominent companies in the esoteric testing market. These companies focus on the introduction of new technologies, upgrading of existing products, and expansion of their geographic reach to meet the growing consumer demand worldwide.